Advanced Enzyme Technologies Balance Sheet Health
Financial Health criteria checks 6/6
Advanced Enzyme Technologies has a total shareholder equity of ₹13.0B and total debt of ₹388.6M, which brings its debt-to-equity ratio to 3%. Its total assets and total liabilities are ₹14.4B and ₹1.5B respectively. Advanced Enzyme Technologies's EBIT is ₹1.6B making its interest coverage ratio 103.8. It has cash and short-term investments of ₹4.7B.
Key information
3.0%
Debt to equity ratio
₹388.61m
Debt
Interest coverage ratio | 103.8x |
Cash | ₹4.68b |
Equity | ₹12.99b |
Total liabilities | ₹1.45b |
Total assets | ₹14.44b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 540025's short term assets (₹7.4B) exceed its short term liabilities (₹874.0M).
Long Term Liabilities: 540025's short term assets (₹7.4B) exceed its long term liabilities (₹577.8M).
Debt to Equity History and Analysis
Debt Level: 540025 has more cash than its total debt.
Reducing Debt: 540025's debt to equity ratio has reduced from 7.2% to 3% over the past 5 years.
Debt Coverage: 540025's debt is well covered by operating cash flow (341.5%).
Interest Coverage: 540025's interest payments on its debt are well covered by EBIT (103.8x coverage).